Source:http://linkedlifedata.com/resource/pubmed/id/12060133
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2002-6-12
|
pubmed:abstractText |
Donor lymphocyte infusions (DLI) can induce a graft-versus-leukaemia (GvL) reaction in patients with relapsed disease. However, the mechanisms involved in remission induction are not completely known. A patient with chemotherapy-refractory relapse 1 year after human leucocyte antigen (HLA)-identical, unrelated stem cell transplantation (SCT) for bcr/abl-positive common acute lymphoblastic leukaemia (ALL) received a DLI from the original donor, and achieved complete cytogenetic and molecular remission concomitantly with extensive graft-versus-host disease (GvHD). Seven CD8+, donor-derived, alloreactive T-cell clones were generated by stimulating post-DLI remission cells with the patient's pretransplant mature dendritic cells. The minor histocompatibility antigen (mHag) recognized by these T-cell clones was identified as HA-1, a mHag associated with acute GvHD after SCT. Our finding provides evidence of HA-1-associated GvL effects after DLI that paralleled the eradication of full-blown, chemotherapy-refractory ALL relapse after allogeneic SCT.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0007-1048
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
117
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
935-9
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12060133-Adult,
pubmed-meshheading:12060133-CD8-Positive T-Lymphocytes,
pubmed-meshheading:12060133-Clone Cells,
pubmed-meshheading:12060133-Dendritic Cells,
pubmed-meshheading:12060133-Graft vs Host Disease,
pubmed-meshheading:12060133-Graft vs Leukemia Effect,
pubmed-meshheading:12060133-Humans,
pubmed-meshheading:12060133-Lymphocyte Transfusion,
pubmed-meshheading:12060133-Male,
pubmed-meshheading:12060133-Minor Histocompatibility Antigens,
pubmed-meshheading:12060133-Oligopeptides,
pubmed-meshheading:12060133-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:12060133-Remission Induction,
pubmed-meshheading:12060133-T-Lymphocytes, Cytotoxic,
pubmed-meshheading:12060133-Transplantation, Homologous
|
pubmed:year |
2002
|
pubmed:articleTitle |
Induction of HA-1-specific cytotoxic T-cell clones parallels the therapeutic effect of donor lymphocyte infusion.
|
pubmed:affiliation |
Laboratory for Tumour- and Immunobiology, Bone Marrow Transplant Unit, Division of Haematology and Oncology, Department of Internal Medicine, Innsbruck University Hospital, Anichstrasse 35, 6020 Innsbruck, Austria. brigitte.eibl@uklibk.ac.at
|
pubmed:publicationType |
Journal Article,
Case Reports
|